Considering the immunological status, neither autoantibody positivity (IgA/IgM-RF, anti-Ro (SSA) and anti-La (SSB)) nor serum complement levels at diagnosis were significantly associated with the development of NHL in the primary Sjögren’s disease cohort (Table 1). The gene discussed is CALR; the disease is non-Hodgkin lymphoma.